SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-202688
Filing Date
2021-06-29
Accepted
2021-06-29 08:22:33
Documents
14
Period of Report
2021-06-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d127009d8k.htm   iXBRL 8-K 25766
2 EX-99.1 d127009dex991.htm EX-99.1 9417
6 GRAPHIC g127009g0629053403321.jpg GRAPHIC 4937
  Complete submission text file 0001193125-21-202688.txt   173039

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20210629.xsd EX-101.SCH 2915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20210629_lab.xml EX-101.LAB 18907
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20210629_pre.xml EX-101.PRE 11878
7 EXTRACTED XBRL INSTANCE DOCUMENT d127009d8k_htm.xml XML 3532
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 211055795
SIC: 2834 Pharmaceutical Preparations